Literature DB >> 1969118

The effects of quinpirole and fenoldopam on the potassium-evoked overflow of endogenous dopamine and noradrenaline in dog mesenteric arteries.

P Soares-da-Silva1.   

Abstract

(1) Dopamine and noradrenaline overflow from the main trunk of the dog mesenteric artery and its proximal branches, elicited by K+ (52 mmol/l), was measured by high pressure liquid chromatography with electrochemical detection. (2) Quinpirole (0.1, 1 and 10 nmol/l) produced a concentration dependent reduction of dopamine and noradrenaline overflow in both segments of the mesenteric artery. The inhibitory effect of quinpirole (10 nmol/l) on amine overflow was antagonized by sulpiride (1 mumol/l) but not by phentolamine (0.2 mumol/l) or the selective dopamine (DA1), antagonist SK&F 83566 (1 mumol/l). (3) Fenoldopam (0.1 and 1 mumol/l) did not alter dopamine and noradrenaline overflow from both segments of the mesenteric artery; only 10 mumol/l fenoldopam was found to increase the overflow of dopamine and noradrenaline in both segments of the mesenteric artery. This effect of fenoldopam on amine overflow was not altered by the addition to the perifusion fluid of SK&F 83566 (1 mumol/l). (4) Clonidine (100 nmol/l) significantly reduced amine overflow from both segments of the mesenteric artery and this effect was antagonized by fenoldopam (10 mumol/l). (5) These results suggest that quinpirole inhibits sympathetic neurotransmission through the activation of prejunctional dopamine receptors of the DA2 subtype. The facilitatory effect of fenoldopam (10 mumol/l) on amine release appears to be mediated through the blockade of prejunctional alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969118     DOI: 10.1007/bf00195055

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  A comparison between the pattern of dopamine and noradrenaline release from sympathetic neurones of the dog mesenteric artery.

Authors:  P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

2.  Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery.

Authors:  P Soares-da-Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

Review 3.  A comparison of the vascular dopamine receptor with other dopamine receptors.

Authors:  L I Goldberg; P H Volkman; J D Kohli
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

4.  Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.

Authors:  A G Dupont; R A Lefebvre; P Vanderniepen
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

Review 5.  Presynaptic alpha-autoreceptors.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1987       Impact factor: 5.545

6.  The DA1 receptor agonist fenoldopam (SK & F 82526) is also an alpha 2-adrenoceptor antagonist.

Authors:  E H Ohlstein; B Zabko-Potapovich; B A Berkowitz
Journal:  Eur J Pharmacol       Date:  1985-12-03       Impact factor: 4.432

7.  Fibroblasts and sympathetic innervation of blood vessels.

Authors:  P Soares-da-Silva; I Azevedo
Journal:  Blood Vessels       Date:  1985

8.  Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.

Authors:  R J Shebuski; T Fujita; J M Smith; L J Kopaciewicz; A L Blumberg; J P Hieble
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

9.  Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.

Authors:  R A Hahn; J R Wardell; H M Sarau; P T Ridley
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

10.  Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.

Authors:  J D Kohli; D Glock; L I Goldberg
Journal:  J Cardiovasc Pharmacol       Date:  1988-01       Impact factor: 3.105

View more
  1 in total

1.  In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist.

Authors:  S S Ng; C C Pang
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.